Distinguished in Primary Hyperoxaluria

Sandrine Lemoine

Faculté De Médecine Lyon Est, 
Lyon, FR 
Distinguished in Primary Hyperoxaluria
Faculté De Médecine Lyon Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Sandrine Lemoine practices in Lyon, France. Ms. Lemoine is rated as a Distinguished expert by MediFind in the treatment of Primary Hyperoxaluria. Her top areas of expertise are Nephrocalcinosis, Primary Hyperoxaluria, Renal Tubular Acidosis, Kidney Transplant, and Nephrectomy.

Her clinical research consists of co-authoring 156 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Primary Hyperoxaluria.

Gender
Female

Locations

Faculté De Médecine Lyon Est, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Fluconazole
Study Phase: Phase 2
Impact of a Ciclosporin A Preconditioning for Prevention of Ischemia-reperfusion Injury After Renal Artery Stenosis Dilation
Impact of a Ciclosporin A Preconditioning for Prevention of Ischemia-reperfusion Injury After Renal Artery Stenosis Dilation
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Drug
Study Drugs: Ciclosporin A, NaCl
Study Phase: Phase 2
Plasma Oxalate in Patient With Short Bowel
Plasma Oxalate in Patient With Short Bowel
Enrollment Status: Completed
Publish Date: July 21, 2022
Intervention Type: Biological, Procedure
View 3 Less Clinical Trials

156 Total Publications

Transition of patients with hereditary nephropathies from pediatric to adult care.
Transition of patients with hereditary nephropathies from pediatric to adult care.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lemoine's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile